A detailed history of Susquehanna International Group, LLP transactions in Replimune Group, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 43,380 shares of REPL stock, worth $542,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,380
Previous 184,023 76.43%
Holding current value
$542,250
Previous $1.66 Million 71.32%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.09 - $11.23 $1.14 Million - $1.58 Million
-140,643 Reduced 76.43%
43,380 $475,000
Q2 2024

Aug 15, 2024

BUY
$5.01 - $9.46 $438,420 - $827,835
87,509 Added 90.67%
184,023 $1.66 Million
Q1 2024

May 07, 2024

BUY
$6.87 - $9.31 $538,841 - $730,220
78,434 Added 433.82%
96,514 $788,000
Q4 2023

Feb 14, 2024

SELL
$6.75 - $16.18 $361,995 - $867,717
-53,629 Reduced 74.79%
18,080 $152,000
Q3 2023

Nov 14, 2023

SELL
$15.96 - $22.18 $962,691 - $1.34 Million
-60,319 Reduced 45.69%
71,709 $1.23 Million
Q2 2023

Aug 11, 2023

BUY
$15.65 - $24.1 $720,056 - $1.11 Million
46,010 Added 53.49%
132,028 $3.07 Million
Q1 2023

May 16, 2023

BUY
$17.48 - $29.09 $1.14 Million - $1.9 Million
65,475 Added 318.72%
86,018 $1.52 Million
Q4 2022

Feb 14, 2023

SELL
$17.09 - $27.91 $368,460 - $601,739
-21,560 Reduced 51.21%
20,543 $558,000
Q3 2022

Nov 14, 2022

BUY
$15.6 - $21.15 $656,806 - $890,478
42,103 New
42,103 $727,000
Q1 2022

May 16, 2022

SELL
$15.24 - $29.75 $196,626 - $383,834
-12,902 Reduced 20.82%
49,072 $833,000
Q4 2021

Feb 14, 2022

BUY
$25.43 - $34.25 $526,579 - $709,214
20,707 Added 50.18%
61,974 $1.68 Million
Q3 2021

Nov 15, 2021

SELL
$28.98 - $39.54 $588,207 - $802,543
-20,297 Reduced 32.97%
41,267 $1.22 Million
Q2 2021

Aug 11, 2021

BUY
$28.5 - $39.37 $356,848 - $492,951
12,521 Added 25.53%
61,564 $2.37 Million
Q1 2021

May 17, 2021

BUY
$30.22 - $45.57 $745,708 - $1.12 Million
24,676 Added 101.27%
49,043 $1.5 Million
Q4 2020

Feb 16, 2021

BUY
$23.5 - $52.65 $572,624 - $1.28 Million
24,367 New
24,367 $930,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $616M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.